How should an elevated ammonia level in an adult be evaluated and treated?

Elevated Ammonia Level: Evaluation and Treatment

In adults with elevated ammonia, immediately assess for hepatic encephalopathy in those with known liver disease, but critically, a normal ammonia level essentially rules out hepatic encephalopathy as the cause of altered mental status, while severe hyperammonemia (>200-250 μmol/L) requires urgent consideration of non-hepatic causes and may necessitate emergent renal replacement therapy to prevent fatal cerebral edema. 1, 2

Initial Diagnostic Approach

When to Measure Ammonia

Measure plasma ammonia in any patient presenting with:

• Unexplained altered mental status, confusion, or encephalopathy
• Delirium with suspected but uncertain liver disease
• Seizures of unclear etiology
• Unexplained stupor or coma 1, 2, 3

A normal ammonia level (<60 μmol/L) casts serious doubt on hepatic encephalopathy as the diagnosis and should prompt investigation of alternative causes of neuropsychiatric symptoms 1, 2. This is a critical clinical decision point that is underutilized in emergency departments 4.

Proper Collection Technique

Ammonia measurement requires strict adherence to collection protocols 2:

• Draw blood on ice
• Process immediately (within 15 minutes)
• Avoid hemolysis and prolonged tourniquet time
• Improper collection yields falsely elevated results

Risk Stratification by Ammonia Level

Mild-Moderate Elevation (60-200 μmol/L)

• Typically seen in chronic liver disease with hepatic encephalopathy
• May be tolerated in cirrhotic patients
• Focus on identifying precipitants (infection, GI bleeding, constipation, medications)

Severe Hyperammonemia (>200-250 μmol/L)

This represents a medical emergency requiring immediate intervention 3, 5:

• High risk of fatal cerebral edema, particularly in non-cirrhotic causes
• Consider urgent renal replacement therapy (hemodialysis or hemofiltration)
• Patients with non-hepatic causes tolerate severe elevations poorly compared to cirrhotics

Differential Diagnosis Framework

Hepatic Causes (Most Common)

• Cirrhosis with hepatic encephalopathy (Type C)
• Acute liver failure (Type A)
• Portosystemic shunts without cirrhosis (Type B)

Non-Hepatic Causes (Increasingly Recognized)

When ammonia is >100 μmol/L with minimal liver dysfunction, strongly suspect 2, 5:

1. Urea cycle disorders (ornithine transcarbamylase deficiency most common in adults)

   • Look for: family history of liver/neurological disease, recurrent episodes, protein intolerance
   • May present in adulthood during catabolic stress

2. Urease-producing infections (13-22% of non-cirrhotic cases) 5

   • Urinary tract infections with Proteus, Klebsiella
   • Helicobacter pylori
   • Empiric antibiotics targeting urease-producers often warranted

3. Medication-induced

   • Valproic acid (most common drug cause)
   • 5-fluorouracil chemotherapy
   • L-asparaginase 6

4. Hematologic malignancies with high tumor burden 5, 6

5. Acquired urea cycle dysfunction 5

   • Severe protein malnutrition (reversible risk factor)
   • Critical illness
   • Post-bariatric surgery

Immediate Management

For Severe Hyperammonemia (>250 μmol/L)

Initiate renal replacement therapy urgently - this is first-line treatment for acute severe hyperammonemia of any cause in adults 3, 7:

• Hemodialysis preferred over peritoneal dialysis (more efficient ammonia clearance)
• Continuous venovenous hemofiltration acceptable alternative
• Do not delay for diagnostic workup completion

Medical Management

For hepatic encephalopathy specifically 1:

• Lactulose: titrate to 2-3 soft bowel movements daily
• Rifaximin 550 mg twice daily as adjunct for recurrent episodes
• Identify and treat precipitants aggressively

For non-hepatic causes:

• Protein restriction (0.5-1 g/kg/day initially)
• Empiric antibiotics if infection suspected
• Discontinue offending medications
• Consider ammonia scavengers (sodium benzoate, sodium phenylacetate) in consultation with metabolic specialists

Supportive Care

• ICU admission for Grade 3-4 encephalopathy (risk of aspiration) 1
• Intubation for airway protection if Glasgow Coma Scale declining
• Avoid sedatives that worsen encephalopathy when possible

Diagnostic Workup

Essential Testing

Brain imaging (CT or MRI) indicated when 1:

• Diagnostic uncertainty
• Non-response to standard HE treatment
• Focal neurological findings
• Note: No imaging proves HE diagnosis, but helps exclude alternatives

Metabolic workup for suspected urea cycle disorder 5:

• Plasma amino acids (elevated glutamine, low citrulline suggests OTC deficiency)
• Urine orotic acid (elevated in OTC deficiency)
• Genetic testing for urea cycle enzyme defects
• Consider in any adult with severe hyperammonemia and minimal liver disease

Infectious workup:

• Urine culture
• Blood cultures
• Consider H. pylori testing

Common Pitfalls

1. Assuming all hyperammonemia is hepatic - non-cirrhotic causes have worse outcomes if missed and account for a significant minority of cases 5

2. Measuring ammonia to "confirm" hepatic encephalopathy - this is not recommended; ammonia can be elevated in cirrhosis without encephalopathy 2

3. Delaying renal replacement therapy - in severe non-hepatic hyperammonemia, cerebral edema can be rapidly fatal; dialysis should not await definitive diagnosis 3, 7

4. Improper specimen collection - leads to falsely elevated results and unnecessary workup 2

5. Underutilization in unexplained encephalopathy - only 3.8% of ED patients with confusion/encephalopathy had ammonia measured in one study, potentially missing metabolic diagnoses 4

Prognosis and Follow-up

• Mortality in non-cirrhotic hyperammonemia: 13-39% depending on cause and severity 5
• Irreversible neurological damage occurs in 4% of survivors 5
• First episode of overt hepatic encephalopathy warrants liver transplant evaluation 1
• Recurrent/persistent HE requires secondary prophylaxis with lactulose, adding rifaximin after second episode within 6 months 1